Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.48 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.48 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3210926 | 0.94 | KMT2A (0.80) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3198349 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3217580 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3206447 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3215274 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3217713 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL3218482 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL13928786 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL21777162 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT | |
| SCHEMBL19618006 | 0.92 | KMT2A (0.84) | MEN1TP53CYP1A2CYP2D6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119585421-A | Enzyme electrode, enzyme reaction device, enzyme reaction method, modified protein, and method for producing modified protein | 松下知识产权经营株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-119585422-A | Enzyme electrode, reduction device, reduction method, modified protein, and method for producing modified protein | 松下知识产权经营株式会社 | 2025-03-07 | — | — | CN | disclosed |
| US-20230192692-A1 | MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF | TIANJIN NORMAL UNIVERSITY (CN) | 2023-06-22 | — | — | US | disclosed |
| EP-4169932-A1 | METHOD FOR CLEAVING DISULFIDE BOND IN PROTEIN AND DEVICE FOR CLEAVING DISULFIDE BOND IN PROTEIN | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2023-04-26 | — | — | EP | disclosed |
| US-20230117095-A1 | TARGET MOLECULE REDOX METHOD AND TARGET MOLECULE REDOX DEVICE | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2023-04-20 | — | — | US | disclosed |
| CN-115916798-A | Method and apparatus for cleaving disulfide bond in protein | 松下知识产权经营株式会社 | 2023-04-04 | — | — | CN | disclosed |
| CN-115702344-A | Target molecule redox method and target molecule redox device | 松下知识产权经营株式会社 | 2023-02-14 | — | — | CN | disclosed |
| US-11215935-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2022-01-04 | — | — | US | disclosed |
| US-11169455-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200341392-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-9190695-B2 | Nonaqueous electrolyte solution, method for producing same, and nonaqueous electrolyte battery using the electrolyte solution | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| EP-2602855-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEM IND LTD (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-20140212459-A1 | 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | TRIOPTOTEC GMBH (DE) | 2014-07-31 | — | — | US | disclosed |
| EP-2602856-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Wako Pure Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2602855-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | Wako Pure Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130143129-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20130130128-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-8269038-B2 | Process for production of sulfonic acid ester | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-09-18 | — | — | US | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | MEN1 3623/4885TP53 4469/4885CYP1A2 337/4885 |
| US-20140212459-A1 | 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | DHPS, DOHH, PAH | MEN1 1722/4885TP53 3520/4885CYP1A2 325/4885 |
| US-20230192692-A1 | MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF | TPMT, NUDT1, PNP | MEN1 4771/4885TP53 180/4885CYP1A2 870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.